Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease

Metformin and liraglutide are used in the treatment of type 2 diabetes mellitus (T2DM) complicated with nonalcoholic fatty liver disease (NAFLD). Although these drugs can alter the intestinal microbiome, clinical data are required to explore their mechanisms of action. Using 16S sequencing technolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Xing, Rongjiong, Zheng, Kahaer, Mayila, Chunhui, Jiang, Wulasihan, Muhuyati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909237/
https://www.ncbi.nlm.nih.gov/pubmed/36778868
http://dx.doi.org/10.3389/fmicb.2023.1088187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909237/
https://www.ncbi.nlm.nih.gov/pubmed/36778868
http://dx.doi.org/10.3389/fmicb.2023.1088187

Ejemplares similares